|
|
|
|
| Symbol | Name | Industry | Sector | Exchange | Cap | Cap, mln | Last | Change | Change, % | Volume |
| |
Agilent Technologies Inc | Diagnostics & Research | Healthcare | NYSE | Large | 37,947 |
132.14 |
-3.25 | -2.4 | 2,432,609 |
| |
Columbia AAA CLO Etf | Exchange Traded Fund | Financial Services Etf | NYSE | | |
20.05 |
0 | 0 | 154 |
| |
ATA Creativity Global ADR | Education & Training Services | Consumer Defensive | NASDAQ | Micro | 35.59 |
0.90 |
-0.13 | -12.62 | 37,046 |
| |
Alpha Architect US Equity 2 Etf | Exchange Traded Fund | Financial Services Etf | NASDAQ | Small | 476.23 |
49.13 |
-0.49 | -0.99 | 13,109 |
| |
American Airlines Group Inc | Airlines | Industrials | NASDAQ | Mid | 8,782 |
14.01 |
0.32 | 2.34 | 47,846,752 |
| |
Leverage Shares 2X Long AAL Daily Etf | Exchange Traded Fund | Financial Services Etf | NASDAQ | Micro | 1.27 |
14.45 |
0.72 | 5.24 | 9,042 |
| |
Atlantic American Corp | Insurance - Life | Financial Services | NASDAQ | Micro | 55.28 |
2.69 |
0.01 | 0.37 | 7,443 |
| |
Acadian Asset Management Inc | Asset Management | Financial Services | NYSE | Small | 1,984.7 |
51.67 |
-4.18 | -7.48 | 376,576 |
| |
Direxion Daily AAPL Bear 1X Shares | Exchange Traded Fund | Financial Services Etf | NASDAQ | Micro | 17.57 |
13.23 |
0.03 | 0.23 | 9,554,341 |
| |
Ascentage Pharma Group International ADR | Biotechnology | Healthcare | NASDAQ | Mid | 2,262.05 |
23.33 |
0.16 | 0.69 | 2,238 |
|
Please sign up to view the complete list of stocks. |
|
|
 Relative Strength Index (RSI) - Technical Analysis from A to Z
The Relative Strength Index ("RSI") is a popular oscillator. Welles Wilder first introduced it in an article in Commodities Magazine in June 1978. When Wilder introduced the RSI, he recommended using a 14-day RSI. Since then, the 9-day and 25-day RSIs have also gained popularity. Because you can vary the number of periods in the RSI calculation, you should experiment to find the period that works best for you - the fewer days used to calculate the RSI, the more volatile the indicator.
|
|
| |
